Dr. Moritsugu joined the Johnson & Johnson Family of Companies on October 1 and will serve as Chairman of the Institute, with responsibility for overseeing the Institute and developing other innovative programs and strategies that will help Johnson & Johnson and the health care community better address the delivery of diabetes care around the world. Born in Hawaii, Dr. Moritsugu achieved Admiralty status within the Commissioned Corps of the U.S. Public Health Service, was the Federal representative to numerous national health care agencies and consulted with several international organizations and governments. Before serving as Acting Surgeon General in 2006, Dr. Moritsugu was the Deputy Surgeon General and the principal assistant and advisor to the U.S. Surgeon General. Having completed residencies in internal medicine and in preventive medicine, Dr. Moritsugu is also Board Certified in preventive medicine and holds Fellowships in the American College of Preventive Medicine, the Royal Society of Health, and the Royal Society of Medicine.
About Johnson & Johnson
Johnson & Johnson is the world's most comprehensive and broadly based
manufacturer of health care products, as well as a provider of related
services, for the consumer, pharmaceutical, and medical devices and
diagnostics markets. The more than 250 Johnson & Johnson operating
companies employ approximately 120,000
'/>"/>
| SOURCE Johnson & Johnson Copyright©2007 PR Newswire. All rights reserved |